Recent Courses

Focus on Idiopathic Pulmonary Fibrosis: Advancing Approaches to Diagnosis,...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic progressive fibrotic lung disease of unknown cause. Early diagnosis is a prerequisite for earlier treatment and, potentially, improved long-term clinical outcomes. Familiarity with novel treatment approaches that hold the promise of slowing disease progression and with the recent...
Patient-centered Care for Genitourinary Cancers
  • 1.25 ACPE credits
  • 1.25 AMA PRA Category 1 Credit(s)™ credits
  • 1.20 Nursing Contact Hours credits
  • 1.25 Non-physician credits
Community oncologists are challenged to stay up to date with updated clinical practice guidelines on the personalization of treatments for genitourinary (GU) cancers, including prostate, urothelial, and renal cancers, combination/sequential therapies, emerging safety and efficacy data from ongoing studies of novel regimens, and strategies to...
An Update on Scientific Advances and Clinical Strategies in Seizure Disorders
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
The 71st American Epilepsy Society (AES) Annual Meeting was held in Washington, DC, December 1-5, 2017. The conference attracts clinicians, scientists investigating basic and clinical aspects of epilepsy, and other professionals interested in seizure disorders. In this activity, 2 experts summarize the key learnings from this year’s conference...
Spotlight on the Critical Issues in the Treatment of Fabry Disease
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
This webcast was recorded during a live symposium at the American Society of Human Genetics (ASHG) Annual Meeting in Orlando, FL, USA, on October 19, 2017. During the symposium, the faculty of leading KOLs in the field provided an overview of the clinical picture of Fabry disease and its natural history. They offered guidance on identifying the...
Looking Beneath the Surface in Atopic Dermatitis
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This activity is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.This activity is jointly provided by Global Education Group and Integritas Communications.TARGET AUDIENCE The educational design of this activity addresses the needs of dermatologists, allergists, and other clinicians who treat patients with atopic...
MSParis2017: Clinical Updates on Disease Modifying Therapies to Improve...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This educational activity will feature content presented at the MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France. Four expert faculty will examine recent prognosis and diagnostic strategies of multiple sclerosis. An analysis of clinical trial data of current and emerging disease modifying therapies as presented at the Joint ACTRIMS...
Individualizing Maintenance Therapy For Patients With COPD
  • 0.25 AANP credits
  • 0.25 AMA PRA Category 1 Credit(s)™ credits
  • 0.25 Non-physician credits
This CME-accredited CME Snapshot™ educational series, Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care, is intended for primary care clinicians and other health care providers involved in the ongoing management of patients with chronic obstructive pulmonary disease (COPD). Within each...
AHA 2017: Applying PCSK9 Inhibitors to Improve Outcomes and the Overall Quality...
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
This Elsevier Conference Reporter will cover data presented at the American Heart Association (AHA) Scientific Session 2017 held in Anaheim, CA. The expert faculty will discuss the role of PCSK9 inhibitors for the treatment of dyslipidemia including achieving LDL-C goals, cardiovascular risk reduction and managing special patient populations....
Applying PCSK9 Inhibitors to Optimize Outcomes in Patients with Dyslipidemia
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Non-physician credits
The content for this activity is derived from a live symposium titled, “Applying PCSK9 Inhibitors to Optimize Outcomes in Patients With Dyslipidemia” presented at the American Heart Association Scientific Sessions 2017 in Anaheim, California. This CME activity will highlight optimal treatment and management strategies for patients with...
The Emerging Role of CFTR Combination Regimens in Improving Outcomes for...
  • 1.50 AMA PRA Category 1 Credit(s)™ credits
  • 1.50 Nursing Contact Hours credits
  • 1.50 Non-physician credits
The content for this activity is based on the live, inter professional seminar titled, “The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis” that was presented at the 31st Annual North American Cystic Fibrosis Conference in Indianapolis, Indiana. This CME/CNE activity will highlight the latest...

Pending Activities

Please login or create an account to view your activities.

Transcript

Please login or create an account to view your activities.